Global Digital Therapeutics Market Research 2023: Market to Reach $46.8 Billion by 2033 from $4.9 Billion in 2022, Driven by Increasing Demand for Cost-Effective Solutions [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
Channel, and Country - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global digital therapeutics market is projected to reach $46.80 billion by 2033 from $4.90 billion in 2022, growing at a CAGR of 22.93% during the forecast period 2023-2033 The key factors driving the growth of the global digital therapeutics market include the multiple benefits offered by digital therapeutics over traditional treatment, continuous technological advancements in the field, and increasing demand for cost-effective solutions. The global digital therapeutics market consists of evidence-based and clinically evaluated software and devices. These tools are designed for the treatment of diverse diseases and disorders. Additionally, digital therapeutics can be employed either independently or in conjunction with devices to address both physical and behavioral health conditions. Market Demand Drivers: Multiple Benefits Provided by Digital Therapeutics
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $205.00 to $200.00. They now have an "outperform" rating on the stock.MarketBeat
- Why ResMed Stock Is Soaring Today [Yahoo! Finance]Yahoo! Finance
- ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Royal Bank of Canada from $187.00 to $200.00. They now have a "sector perform" rating on the stock.MarketBeat
- ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand [Yahoo! Finance]Yahoo! Finance
- ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $227.00 to $238.00. They now have an "overweight" rating on the stock.MarketBeat
RMD
Earnings
- 4/25/24 - Beat
RMD
Sec Filings
- 4/29/24 - Form 144
- 4/26/24 - Form 10-Q
- 4/25/24 - Form 8-K
- RMD's page on the SEC website